Alkem Laboratories Limited — Important, 07-02-2025: General Updates

Alkem Laboratories is set to strengthen its position in the orthopedic sector by acquiring a 100% stake in Bombay Ortho Industries for INR 147 crores (approximately Rupees One Hundred Forty-Seven Crores). This strategic investment aims to enhance Alkem Medtech's manufacturing capabilities, specifically targeting the growing market for hip and knee implants. The acquisition, which does not involve related party transactions, is expected to be completed by June 30, 2025, following a cash payment structured in four tranches and subject to certain adjustments at closing. Bombay Ortho, established in May 2021, reported a turnover of INR 5.5 crores for the financial year ending March 31, 2024, after generating initial revenue in previous years. This move could provide Alkem with significant growth opportunities in the healthcare market. Investors should monitor this acquisition closely, as it may enhance future revenue streams and market competitiveness.